Our focus is to decrease the risk of widely reported and unnecessary hospital acquired infections in line with global action plans on antimicrobial resistance.
Our mission is to fight against the threat of serious infections with a non-antibiotic antimicrobial solution.
SterileCare’s products are focused on improving the quality of care to patients' lives through research and collaborations with healthcare professionals to further develop preventative and treatment related solutions for medical treatment.
Chief Executive Officer (CEO)
Chantal Lainesse, DVM, PhD
Chief Scientific Officer (CSO)
Karen Kelln spent her career in life sciences initially as a registered nurse and then as a top national medical sales executive with multiple layers of experience. She brings strategic and operational planning and execution along with product marketing, sales training and product launching excellence. Her interpersonal and communication skills encourage strong relationships to ensure success for the client, the team and the company.
Dr Lainesse has several years experience in life sciences. She is a veterinarian with a PhD in pharmacology and is a board certified clinical pharmacologist. She gained experience and crucial insight in the regulatory process of drug development when working for Health Canada and in drug discovery when working for one of the largest global pharmaceutical companies (Ely Lilly). Dr Lainesse is currently a member of several national and international scientific societies and holder of various recognized achievement awards. She is also the author of several peer-reviewed scientific journal articles and has appeared as a guest speaker in Canadian universities and conferences around the world.